Search

Your search keyword '"elite controllers"' showing total 217 results

Search Constraints

Start Over You searched for: Descriptor "elite controllers" Remove constraint Descriptor: "elite controllers" Topic hiv-1 Remove constraint Topic: hiv-1
217 results on '"elite controllers"'

Search Results

1. Deep analysis of the major histocompatibility complex genetic associations using covariate analysis and haploblocks unravels new mechanisms for the molecular etiology of Elite Control in AIDS.

2. IL-15-dependent immune crosstalk between natural killer cells and dendritic cells in HIV-1 elite controllers.

Catalog

Books, media, physical & digital resources

3. The HLA-B*57:01 allele corresponds to a very large MHC haploblock likely explaining its massive effect for HIV-1 elite control.

4. Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1.

5. Comparison of the Biological Basis for Non-HIV Transmission to HIV-Exposed Seronegative Individuals, Disease Non-Progression in HIV Long-Term Non-Progressors and Elite Controllers.

6. Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman.

7. Reduced CCR5 expression among Uganda HIV controllers.

8. Naturally occurring dipeptide from elite controllers with dual anti-HIV-1 mechanism.

9. High frequency of CD8 escape mutations in elite controllers as new obstacle for HIV cure.

11. Elite controllers long-term non progressors present improved survival and slower disease progression.

12. Omic Technologies in HIV: Searching Transcriptional Signatures Involved in Long-Term Non-Progressor and HIV Controller Phenotypes.

13. Autophagy-dependent glutaminolysis drives superior IL21 production in HIV-1-specific CD4 T cells.

14. Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control.

15. Inversed Ratio of CD39/CD73 Expression on γδ T Cells in HIV Versus Healthy Controls Correlates With Immune Activation and Disease Progression.

16. Increased biomarkers of cardiovascular risk in HIV-1 viremic controllers and low persistent inflammation in elite controllers and art-suppressed individuals.

17. Peripheral blood CD4 + CCR6 + compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals.

18. High Plasma sTNF-R1 Level Is Related to Loss of Natural HIV Control in Long-Term Elite Controllers.

19. Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller.

20. Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry.

21. Signatures of immune selection in intact and defective proviruses distinguish HIV-1 elite controllers.

22. An HIV elite controller patient carrying the homozygous H63D variant in the homeostatic iron regulator gene: A case report.

23. Lipophagy confers a key metabolic advantage that ensures protective CD8A T-cell responses against HIV-1.

24. Systemic DPP4/CD26 is associated with natural HIV-1 control: Implications for COVID-19 susceptibility.

25. The influence of HLA/HIV genetics on the occurrence of elite controllers and a need for therapeutics geotargeting view.

26. Naive infection predicts reservoir diversity and is a formidable hurdle to HIV eradication.

28. Anti-cytomegalovirus Immunoglobulin G Is Linked to CD4 T-cell Count Decay in Human Immunodeficiency Virus (HIV) Elite Controllers.

29. Quantitative proteomics analysis reveals unique but overlapping protein signatures in HIV infections.

30. A Novel Sample Selection Approach to Aid the Identification of Factors That Correlate With the Control of HIV-1 Infection.

31. Cytotoxic CD8+ T Cells Expressing CXCR5 Are Detectable in HIV-1 Elite Controllers After Prolonged In Vitro Peptide Stimulation.

32. High rates of long-term progression in HIV-1-positive elite controllers.

33. Resistance to human immunodeficiency virus infection: a rare but neglected state.

34. Viral reservoirs in elite controllers of HIV-1 infection: Implications for HIV cure strategies.

35. Maintenance of Viral Suppression in Human Immunodeficiency Virus Controllers Despite Waning T-Cell Responses During Antiretroviral Therapy.

36. Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers.

37. SAMHD1 expression is associated with low immune activation but not correlated with HIV‑1 DNA levels in CD4+ T cells of patients with HIV‑1.

38. A T Cell Receptor Sequencing-Based Assay Identifies Cross-Reactive Recall CD8 + T Cell Clonotypes Against Autologous HIV-1 Epitope Variants.

39. Natural HIV-1 Nef Polymorphisms Impair SERINC5 Downregulation Activity.

40. Learning From the Exceptions: HIV Remission in Post-treatment Controllers.

41. HIV Controllers Exhibit Effective CD8 + T Cell Recognition of HIV-1-Infected Non-activated CD4 + T Cells.

42. Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection.

43. Identification and characterization of HIV positive Ethiopian elite controllers in both Africa and Israel.

44. Case report: mechanisms of HIV elite control in two African women.

45. Human Immunodeficiency Virus Type-1 Elite Controllers Maintain Low Co-Expression of Inhibitory Receptors on CD4+ T Cells.

47. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.

48. Impaired Downregulation of NKG2D Ligands by Nef Proteins from Elite Controllers Sensitizes HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.

49. HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection.

50. Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers.